APA

Katsaros D., Fracchioli S., Arts H. J., de Vries E. G., Danese S., Richiardi G., Arisio R., Gordini G., Van der Zee A. G., Suurmeijer A. J. & Massobrio M. (20000502). [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. : Minerva ginecologica.

Chicago

Katsaros D, Fracchioli S, Arts H J, de Vries E G, Danese S, Richiardi G, Arisio R, Gordini G, Van der Zee A G, Suurmeijer A J and Massobrio M. 20000502. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. : Minerva ginecologica.

Harvard

Katsaros D., Fracchioli S., Arts H. J., de Vries E. G., Danese S., Richiardi G., Arisio R., Gordini G., Van der Zee A. G., Suurmeijer A. J. and Massobrio M. (20000502). [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. : Minerva ginecologica.

MLA

Katsaros D, Fracchioli S, Arts H J, de Vries E G, Danese S, Richiardi G, Arisio R, Gordini G, Van der Zee A G, Suurmeijer A J and Massobrio M. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. : Minerva ginecologica. 20000502.